The one-year incidence of shopping behavior was 8.4% for buprenorphine patients.
No shopping behavior was identified within the first year for methadone patients.
Male, low-income, use of hypnotics, morphine and weak opioids were risk factors.
These risk factors were similar to those identified for opioid abuse.
Shoppers overall mortality, compared with non-shoppers, increased by 50%.